Health
CRISPR/Cas9 system is highly effective in treating metastatic cancers – News-Medical.Net
Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the…
Reviewed by Emily Henderson, B.Sc.Nov 19 2020
Researchers at Tel Aviv University (TAU) have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer.
The researchers developed a novel lipid nanoparticle-based delivery system that specifically targets cancer cells and destroys them by genetic manipulation.
The system, called CRISPR-LNPs, carries a genetic messenger (messenger RNA), which encodes for the CRISPR…
-
Noosa News12 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General20 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
General14 hours agoAustralian luger Alex Ferlazzo makes stunning recovery during run after falling off his sled
-
Business24 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
